newsfilter
← Latest News
PR Newswire·

Oramed to Present at H.C. Wainwright 24th Annual Global Investment Conference

NEW YORK, Sept. 6, 2022 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Executive Office